| Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure R Ferrari, T Bachetti, R Confortini, C Opasich, O Febo, A Corti, G Cassani, ... Circulation 92 (6), 1479-1486, 1995 | 788 | 1995 |
| Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. MP Stoppelli, A Corti, A Soffientini, G Cassani, F Blasi, RK Assoian Proceedings of the National Academy of Sciences 82 (15), 4939-4943, 1985 | 652 | 1985 |
| The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. E Appella, EA Robinson, SJ Ullrich, MP Stoppelli, A Corti, G Cassani, ... Journal of Biological Chemistry 262 (10), 4437-4440, 1987 | 642 | 1987 |
| Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13) F Curnis, A Sacchi, L Borgna, F Magni, A Gasparri, A Corti Nature biotechnology 18 (11), 1185-1190, 2000 | 543 | 2000 |
| Autocrine saturation of pro-urokinase receptors on human A431 cells MP Stoppelli, C Tacchetti, MV Cubellis, A Corti, G Cassani, E Appella, ... Cell 45 (5), 675-684, 1986 | 432 | 1986 |
| Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy F Pastorino, C Brignole, D Marimpietri, M Cilli, C Gambini, D Ribatti, ... Cancer research 63 (21), 7400-7409, 2003 | 397 | 2003 |
| Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells F Curnis, G Arrigoni, A Sacchi, L Fischetti, W Arap, R Pasqualini, A Corti Cancer research 62 (3), 867-874, 2002 | 380 | 2002 |
| Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration F Curnis, A Sacchi, A Corti The Journal of clinical investigation 110 (4), 475-482, 2002 | 334 | 2002 |
| Modulation of metastatic potential by cell surface urokinase of murine melanoma cells VJ Hearing, LW Law, A Corti, E Appella, F Blasi Cancer Research 48 (5), 1270-1278, 1988 | 303 | 1988 |
| Targeting liposomal chemotherapy via both tumor cell–specific and tumor vasculature–specific ligands potentiates therapeutic efficacy F Pastorino, C Brignole, D Di Paolo, B Nico, A Pezzolo, D Marimpietri, ... Cancer research 66 (20), 10073-10082, 2006 | 290 | 2006 |
| Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortality C Ceconi, R Ferrari, T Bachetti, C Opasich, M Volterrani, B Colombo, ... European heart journal 23 (12), 967-974, 2002 | 271 | 2002 |
| The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties KB Helle, A Corti, MH Metz-Boutigue, B Tota Cellular and Molecular Life Sciences 64, 2863-2886, 2007 | 258 | 2007 |
| Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif G Colombo, F Curnis, GMS De Mori, A Gasparri, C Longoni, A Sacchi, ... Journal of Biological Chemistry 277 (49), 47891-47897, 2002 | 253 | 2002 |
| Spontaneous formation of L-isoaspartate and gain of function in fibronectin F Curnis, R Longhi, L Crippa, A Cattaneo, E Dondossola, A Bachi, A Corti Journal of Biological Chemistry 281 (47), 36466-36476, 2006 | 231 | 2006 |
| Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function M Pieroni, A Corti, B Tota, F Curnis, T Angelone, B Colombo, MC Cerra, ... European heart journal 28 (9), 1117-1127, 2007 | 224 | 2007 |
| The neovasculature homing motif NGR: more than meets the eye A Corti, F Curnis, W Arap, R Pasqualini Blood, The Journal of the American Society of Hematology 112 (7), 2628-2635, 2008 | 222 | 2008 |
| Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A K Lugardon, R Raffner, Y Goumon, A Corti, A Delmas, P Bulet, D Aunis, ... Journal of biological chemistry 275 (15), 10745-10753, 2000 | 201 | 2000 |
| Oligomeric tumour necrosis factor α slowly converts into inactive forms at bioactive levels A Corti, G Fassina, F Marcucci, E Barbanti, G Cassani Biochemical Journal 284 (3), 905-910, 1992 | 192 | 1992 |
| Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-α A Sacchi, A Gasparri, C Gallo-Stampino, S Toma, F Curnis, A Corti Clinical Cancer Research 12 (1), 175-182, 2006 | 191 | 2006 |
| Coupling Tumor Necrosis Factor-α with αV Integrin Ligands Improves Its Antineoplastic Activity F Curnis, A Gasparri, A Sacchi, R Longhi, A Corti Cancer research 64 (2), 565-571, 2004 | 182 | 2004 |
Flavio CurnisSan Raffaele Scientific InstituteDirección de correo verificada de hsr.it
